Umbilical cord blood stem cells: Application for the treatment of patients with hemoglobinopathies

Journal of Pediatrics

Volumn 130, Issue 5, 1997, Pages 695-703

  Kelly, P ^a   Kurtzberg, J ^a   Vichinsky, E ^a   Lubin, B ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; INFANT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION; THALASSEMIA MAJOR; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 0030815760     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)80009-1     Document Type: Article

References (83)

1. S Piomelli T. Loew Management of thalassemia major (Cooley's anemia) Hematol Oncol Clin North Am 5 1991 557 569
2. E. Vichinsky Comprehensive care in sickle cell disease: its impact on morbidity and mortality Semin Hematol 28 1991 220 226
3. S Charache G Dover R Moore Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia Blood 79 1992 2555 2565
4. S Charache M Terrin R Moore Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia N Engl J Med 332 1995 1317 1322
5. S Perrine N Olivieri D Faller Butyrate derivatives: new agents for stimulating fetal globin production in the B-globin disorders Am J Pediatr Hematol Oncol 16 1994 67 71
6. E Vichinsky B. Lubin A cautionary note regarding hydroxyurea in sickle cell disease Blood 83 1994 1124 1128
7. J Wagner N Kernan M Steinbuch Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease Lancet 346 1995 214 219
8. J Kurtzberg M Laughlin M Graham Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients N Engl J Med 335 1996 157 166
9. H Broxmeyer G Douglas G Hangoc Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells Proc Natl Acad Sci 86 1989 3828 3832
10. N Ende P Rameshwar M. Ende Fetal cord blood's potential for bone marrow transplantation Life Sciences 44 1989 1987 1990
11. D Lynch L Knott C Rodek Studies of circulating hemopoietic progenitor cells in human fetal blood Blood 59 1982 976 979
12. H Broxmeyer L Lu J Gaddy Human umbilical cord blood transplantation: the immunology, expansion and therapeutic applications of hematopoietic stem and progenitor cells D Levitt R Mertelsmann Hematopoietic stem cells biology and therapeutic applications. 1995 Marcel Dekker New York 297 317
13. A Cardoso M-L Li P Batard Release from quiescence of CD34 + CD38 − human umbilical cord blood cells reveals their potentiality to engraft adults Proc Natl Acad Sci 90 1993 8707 8711
14. H Broxmeyer G Hangoc S Cooper Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults Proc Natl Acad Sci 89 1992 4109 4113
15. C Carow G Hangoc H. Broxmeyer Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma Blood 81 1993 942 949
16. L Lu M Xiao R-N Shen Enrichment, Characterization, and responsiveness of single primitive CD34 +++ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential Blood 81 1993 41 48
17. E Gluckman H Broxmeyer AD Auerbach Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilicard-cord blood from an HLA-identical sibling N Engl J Med 321 1989 1174 1178
18. J. Wagner Umbilical cord blood transplantation Transfusion 35 1995 619 621
19. H. Broxmeyer Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in transplantation Transfusion 35 1995 694 702
20. D Linch L. Brent Marrow transplantation: can cord blood be used? [editorial] Nature 340 1989 676
21. D. Nathan The beneficence of neonatal hematopoeisis N Engl J Med 321 1989 1190 1191
22. T Zimmerman W Lee J Bender CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy Prog Clin Biol Res 389 1994 303 308
23. T Zimmerman W Lee J Bender Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests Bone Marrow Transplant 15 1995 439 444
24. P Rubinstein L Dobrila R Rosenfield Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution Proc Natl Acad Sci 92 1995 10119 10122
25. R Gale M Bortin DV Bekkum Risk factors for acute graft-versus-host-disease Br J Haematol 67 1987 397 406
26. M Horowitz M. Bortin Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias: a report from the International Bone Marrow Transplant Registry Am J Pediatr Hematol Oncol 15 1993 56 64
27. R Nash M Pepe R Storb Acute graft-versus-host disease: analysis of risk factors after aloogeneic marrow transplantation and prophylaxis with cyclosporin and methotrexate Blood 80 1992 1838 1845
28. N Kernan G Bartsch R Ash Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program N Engl J Med 328 1993 593 602
29. P Beatty C Anasetti J Hansen Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus Blood 81 1993 249 253
30. K Sullivan E Agura C Anasetti Chronic graft-versus-host disease and other late complications of bone marrow transplantation Semin Hematol 28 1991 250 259
31. R Dopfer D. Niethammer Report on the international workshop of the Kind Philipp Foundation on late effects after bone marrow transplantation in childhood malignancies Pediatr Hematol Oncol 10 1993 63 84
32. J Goldman R Gale M Horowitz Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion Ann Intern Med 108 1988 806 814
33. P Martin J Hansen C Buckner Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts Blood 66 1985 664 672
34. JJV Rood F. Claas The influence of allogeneic cells on the human T and B cell repertoire Science 248 1990 1388 1393
35. J Antin B Bierer B Smith Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies Blood 78 1991 2139 2149
36. M Bortin R Truitt C-Y Shih Graft vs. leukemia reactivity by alloimmunization without augmentation of graft vs. host reactivity Nature 281 1979 490 491
37. C Davenport V Kumar M. Bennett Use of newborn liver cells as a murine model for cord blood cell transplantation J Immunol 151 1993 1597 1605
38. B Johnson R. Truitt Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent anti-leukemic reactivity without severe graft-versus-host disease Blood 85 1995 3302 3312
39. G Risdon J Gaddy M Horie Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells Proc Natl Acad Sci 92 1995 2413 2417
40. M Sykes M Romick D. Sachs Interleukin-2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells Proc Natl Acad Sci 87 1990 5633 5637
41. S Neudorf J Blatt S Corey Graft failure after an umbilical cord blood transplant in a patient with severe aplastic anemia Blood 85 1995 2991 3000
42. J Sanders R Storb C Anasetti Marrow transplant experience for children with severe aplastic anemia Am Pediatr Hematol Oncol 16 1994 43 49
43. N Young A. Barrett The treatment of severe acquired aplastic anemia Blood 85 1995 3367 3377
44. Y Reisner M. Martelli Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol Today 16 1995 437 440
45. E Holler H Kolb J Mittermuller Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor a (TNFa) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFa (MAK 195F) Blood 86 1995 890 899
46. E Thomas C Buckner J Sanders Marrow transplantation in thalassemia Lancet 2 1982 227 229
47. C Giadini M Galimberti G. Lucarelli Bone marrow transplantation in thalassemia Annu Rev Med 46 1995 319 330
48. M Walters E. Thomas Bone marrow transplantation for thalassemia: the USA experience Am J Pediatr Hematol Oncol 16 1994 11 17
49. D. Weatherall Bone marrow transplantation for thalassemia and other inherited disorders of hemoglobin Blood 80 1992 1379 1381
50. S. Ballas Bone-marrow transplantation in sickle-cell anaemia: why so few so late? [letter] Lancet 340 1992 1226
51. R. Nagel The dilemma of marrow transplantation in sickle cell anemia Semin Hematol 28 1991 233 234
52. I Roberts S. Davies Sickle cell disease: the transplant issue Bone Marrow Transplant 11 1993 253 254
53. O Platt E. Guinan Bone marrow transplantation in sickle cell anemia: the dilemma of choice N Engl J Med 335 1996 426 428
54. C Vermylen G. Cornu Bone marrow transplantation for sickle cell disease: the European experience Am J Pediatr Hematol Oncol 16 1994 18 21
55. M Walters M Patience J Sanders Bone marrow transplantation for sickle cell disease N Engl J Med 335 1996 369 376
56. C Vermylen J Ninane EF Robles Bone marrow transplantation in five children with sickle cell anemia Lancet 1 1988 1427 1428
57. C Vermylen G Cornu A Ferster Bone marrow transplantation in sickle cell disease: the Belgian experience Bone Marrow Transplant 12 1993 116 117
58. F Bernaudin G Souillet J Vannier Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience Bone Marrow Transplant 12 Suppl 1 1993 118 121
59. M Walters K Sullivan F Bernaudin Neurologic complications after allogeneic marrow transplantation for sickle cell anemia Blood 85 1995 879 884
60. R Adams V McKie F Nichols The use of transcranial ultrasonography to predict stroke in sickle cell disease N Engl J Med 326 1992 605 610
61. R. Adams Sickle cell disease and stroke J Child Neurol 10 1995 75 76
62. F Moser S Miller J Bello The spectrum of brain MR abnormalities in sickle-cell disease: a report from the cooperative study of sickle cell disease Am J Neuroradiol 17 1996 965 972
63. F Armstrong R Thompson W Wang Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease Pediatrics 97 1996 864 870
64. WC Mentzer S Heller P Pearle Availability of related donors for bone marrow transplant in sickle cell anemia Am J Pediatr Hematol Oncol 16 1994 27 29
65. E Kodish J Lantos C Stocking Bone marrow transplantation for sickle cell disease: a study of parent's decisions N Engl J Med 325 1991 1349 1353
66. E. Gluckman Use of cord blood for treatment of patients with congenital hemoglobinopathies Y Beuzard B Lubin J Rosa Sickle cell disease and thalassaemias: new trends in therapy vol 234 1995 John Libbey Eurotext Ltd London 583 587
67. S Issaragrisil S Visuthisakchai V Suvatte Brief report: transplantation of cord blood cells into a patient with severe thalassemia N Engl J Med 332 1995 367 369
68. S Issaragrisil S Visuthisakchai Y Tangnaitrisorana Cord blood stem cell transplantation in thalassemia [abstract] Blood 86 1995 3788a
69. B Brichard C Vermylen J Ninane Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia J Pediatr 128 1996 241 243
70. I Newton P Charbord JP Schaal Toward cord blood banking: density-separation and cryopreservation of cord blood progenitors Exp Hematol 21 1993 671 674
71. P Rubinstein RE Rosenfeld JW Adamson Stored placental blood for unrelated bone marrow reconstitution Blood 81 1993 1679 1690
72. P Beatty M Mori E. Milford Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor Transplantation 60 1995 778 783
73. F Bertolini C Corsini E Lauri Umbilical cord blood banking: evaluation of the collection procedure and of CFU-GM content J Hematother 2 1993 233 234
74. DT Harris MJ Schumacher S Rychlik Collection, separation and cryopreservation of umbilical cord blood for use in transplantation Bone Marrow Transplant 13 1994 135 143
75. J McCullough ME Clay S Fautsch Proposed policies and procedures for the establishment of a cord blood bank Blood Cells 20 1994 609 626
76. Application of current statutory authorities to human somatic cell therapy products and gene therapy products. U.S. Department of Health and Human Services, Food and Drug Administration, Docket No. 93N-0137 Federal Register 58 1993 53248 53251
77. Draft document concerning the regulation of placental/umbilical cord blood stem cell products intended for transplantation or further manufacture into injectable products: availbility. U.S. Department of Helath and Human Services, Food and Drug Administration, Docket No. 96N-0002 Federal Register 61 1996 7807 7808
78. 3+ hematopoietic stem/progenitor cells from human umbilical cord blood J Exp Med 178 1993 2089 2096
79. S Zhou S Cooper L Kang Adeno-associated virus 2–mediated high-efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood J Exp Med 179 1994 1867 1875
80. J Sugarman E Reisner J. Kurtzberg Ethical aspects of banking placental blood for transplantation JAMA 274 1995 1783 1785
81. E Clayton K Steinberg M Khoury Informed consent for genetic research on stored tissue samples JAMA 274 1995 1786 1792
82. B Knoppers C. Laberge Research and stored tissues: persons as sources, samples as persons? JAMA 274 1995 1806 1807
83. C. Howe Umbilical cord blood for transplantation [editorial] JAMA 275 1996 910